In a murine lung cancer model, combination radiotherapy, anti-PD-1 and anti-Mer, led to suppressed tumor growth, enhanced survival rates, and an overall decrease in metastasis by enhancing the population of CD8+ CD103+ TRM cells at distal tumor sites. Here, MERTK is linked to neoplasm.